A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

BERLIN — Donald Trump's victory in the U.S. presidential election bolsters the case for serious investment in space programs across the Continent, the director general of the European Space Agency ...

The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with ...

Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...

Experts from Duke Cancer Institute discuss the creation of individualized management plans to transition patients from oncologist to primary care physician. Beyond Cancer: A Multidisciplinary ...

Apr. 30, 2024 — A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found ...

In collaboration with the advertising agency Cult, Penn Medicine’s video campaign summarizes the work the health system has done over its 250-year history to help protect the community and ...

Personalized medicine is a therapeutic approach involving the use of an individual’s genetic and epigenetic information to tailor drug therapy or preventive care. Individualized genetic ...